Estimations des analystes de Wall Street pour GeoVax Labs, Inc. (GOVX): objectif de cours de consensus, recommandations achat/conserver/vente et prévisions de revenus, BPA et EBITDA pour les prochains exercices.
Consensus des analystes
| Achat fort | 0 |
| Achat | 6 |
| Conserver | 1 |
| Vente | 0 |
| Vente forte | 0 |
| Analystes au total | 7 |
| Note moyenne (1-5) | 0.86 |
Surprises de Résultats Récentes
| Date | BPA Réel | BPA Estimé | vs Est. |
|---|---|---|---|
| 2026-11-12 | $-1.09 | ||
| 2026-07-27 | $-0.97 | $-2.16 | +55.1% |
| 2026-05-14 | $-2.62 | $-1.60 | -63.7% |
| 2026-04-02 | $-2.29 | $-4.71 | +51.3% |
| 2025-11-13 | $-7.75 | $-5.85 | -32.4% |
| 2025-07-28 | $-8.75 | $-8.69 | -0.7% |
| 2025-05-01 | $-11.25 | $-14.75 | +23.7% |
| 2025-03-27 | $-7.50 | $-19.75 | +62.0% |
Ratios de valorisation
| Prix / Valeur comptable | 1.05 |
| EV / EBITDA | -0.09 |
| Rendement du dividende | 0.00% |
Compte de Résultat (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenus | $828918 | $1.1M | $963000 | $1.2M | $1.8M | $385501 | $81526 | 0 | $4.0M | $2.5M |
| Coût des Ventes | $2.0M | $2.0M | $1.9M | 0 | 0 | $15.6M | $9.1M | $20.7M | $95368 | $18.1M |
| Marge Brute | -$1.1M | -$942080 | -$915652 | $1.2M | $1.8M | -$15.2M | -$9.0M | -$20.7M | $3.9M | -$15.6M |
| R&D | $2.0M | $2.0M | $1.9M | $1.9M | $2.4M | $15.6M | $9.1M | $20.7M | $23.7M | $18.1M |
| Frais Généraux | $2.1M | $1.2M | $1.6M | $1.6M | $2.2M | $3.6M | $5.0M | $5.9M | $5.4M | $6.0M |
| Charges Opérationnelles | $4.1M | $3.2M | $3.5M | $3.5M | $4.6M | $3.6M | $5.0M | $6.0M | $29.0M | $6.0M |
| Résultat Opérationnel | -$3.3M | -$2.2M | -$2.6M | -$2.4M | -$2.8M | -$18.7M | -$14.0M | -$26.7M | -$25.1M | -$21.6M |
| EBITDA | -$3.2M | -$2.1M | -$2.5M | -$2.4M | -$2.8M | -$18.5M | -$14.0M | -$25.9M | -$24.9M | -$21.4M |
| Charges d'Intérêt | 0 | 0 | $2590 | $4495 | $143524 | $1286 | 0 | 0 | $21375 | 0 |
| Résultat Avant Impôts | -$3.3M | -$2.2M | -$2.6M | -$2.4M | -$3.0M | -$18.6M | -$14.0M | -$26.0M | -$25.0M | -$21.5M |
| Impôts | 0 | 0 | $5213 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Résultat Net | -$3.3M | -$2.2M | -$2.6M | -$2.4M | -$3.0M | -$18.6M | -$14.0M | -$26.0M | -$25.0M | -$21.5M |
| BPA | $-32.25 | $-21.25 | $-25.25 | $-23.50 | $-29.00 | $-182.50 | $-138.00 | $-255.50 | $-120.50 | $-22.40 |
| BPA Dilué | $-32.25 | $-21.25 | $-25.25 | $-23.50 | $-29.00 | $-182.50 | $-138.00 | $-255.50 | $-120.50 | $-22.40 |
| Actions en Circulation (Diluées) | $101595 | $101595 | $101595 | $101595 | $101595 | $101595 | $101595 | $101595 | $207482 | $958443 |
Prix
| Prix | $0.41 |
| Capitalisation | $3M |
| Bourse | NASDAQ |
| Pays | US |
Entreprises liées: ADAP · ADTX · AIMD · ANL · APLM · BLRX · ICU
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de GOVX: Vue d'ensemble · Financiers · Valorisation · Statistiques · Technique · Actionnariat · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions